David Demailly, our API Commercial Director was interviewed by SpeakPharma

Published 13 Jun 2022

In the interview, David Demailly discusses Aspen API’s expertise, our solutions and our sustainability efforts. David talks about the opportunities that he sees for the future and the ambitions of Aspen API. Speak Pharma (pharmacompass.com)

“Our API is a critical resource that’s managed in an innovative, competitive way”